SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PBH

Prestige Consumer Healthcare Inc. (New York Stock Exchange:PBH)

US · Delayed Price · Currency is USD
Healthcare · Medical - Pharmaceuticals
$49.63+$0.03 (+0.06%)
 
Market cap
$2.35B
Insider Score
Health Score
Analyst consensus
Listed since
Feb 10, 2005
Market Cap$2.35B-16.5%
Revenue (ttm)$1.17B+5.1%
Net Income$155.10M-22.8%
EPS$3.24-19.6%
Shares Out47.40M
PE Ratio15.22
Forward PE9.77
Dividendn/a
Ex-Dividend DateSep 27, 2018
Volume612,369
Open$50.45
Previous Close$49.60
Day's Range$49.42 - $50.94
52-Week Range$41.77 - $71.07
Beta0.34
AnalystsBuy
Price Target$51.00(+2.76%)
Earnings DateFeb 4, 2027

About PBH

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.

Address
660 White Plains Road, Tarrytown, NY, 10591, US
Market Cap
2.35 billion
Employees
890
Industrial Classification
Medical - Pharmaceuticals

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$120.44K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $51.00 (+0.8%)

1 firm rating PBH in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From PBH’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+0.06%
5 Days
+6.27%
1 Month
+3.57%
6 Months
+2.90%
1 Year
-16.48%

$PBH stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in PBH holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PBH's directors and management

Net Shares Purchased by Insiders−3k−2k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PBH Estimated quarterly lobbying spending

Source: U.S. Senate LDA

PBH Revenue by Segment or Geography

$336.31MTotal
Gastrointestinal$63.11M18.77%
Women's Health$53.59M15.93%
Wellness, Sleep & Other$47.32M14.07%
Dermatologicals$43.86M13.04%
Cough, Cold & Allergy$36.32M10.80%
Eye & Ear Care$34.61M10.29%
Pain Relief$30.89M9.19%
Oral Care$26.60M7.91%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New PBH patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PBH from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in PBH

IJRiShares Core S&P Small-Cap ETF$141.45M
IWMiShares Russell 2000 ETF$62.72M
VTIVanguard Morningstar Total Stock Market ETF$58.33M
VBVanguard Morningstar Small-Cap ETF$52.07M
DFSVU.S. Small Cap Value Portfolio ETF Class Shares$41.18M
VBRVanguard Morningstar Small-Cap Value ETF$33.87M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from PBH’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
85
News & Sentiment
20% of score
62

News check: Q2 earnings beat both revenue and profit estimates with 23% revenue surge, though offset by valuation concerns and guidance reduction concerns.

Recent Insider Activity

Buys
0
Sells
4
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

IBETiBET Sports Betting & Gaming ETF2.67%
PJPInvesco Pharmaceuticals ETF2.59%
SAEFSchwab Ariel ESG ETF2.28%
XPHState Street SPDR S&P Pharmaceuticals ETF1.85%
BSMCBrandes U.S. Small-Mid Cap Value ETF1.63%
PSCHInvesco S&P SmallCap Health Care ETF1.10%
NTRLFirst Trust Merger Arbitrage ETF0.83%
HSMVFirst Trust Horizon Managed Volatility Small/Mid ETF0.78%
JPSVJPMorgan Active Small Cap Value ETF0.57%
NQLTNeuberger Quality Select ETF0.50%
FYTFirst Trust Small Cap Value AlphaDEX Fund0.49%
LITLSimplify Piper Sandler US Small-Cap PLUS Income ETF0.48%

Weight is the stock’s share of each fund’s holdings.